CYTOKINETICS INC — Director's Dealing 2011

Jan 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2011-01-03

Reporting Person: DOW STEPHEN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-03	Stock Option (Right To Buy)	$2.16	A	23148	Acquired	2021-01-03	Common Stock (23148)	Direct

Footnotes

F1: Stock Options vest and are exercisable monthly over a period of twelve months are are fully vested on January 3, 2012.

F2: Options issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of annual retainer of $20,000.